“Ozempic feet” is an informal, social-media term—not a formal medical diagnosis—for changes in the feet that some people notice after rapid or substantial weight loss while using GLP-1 medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). The term usually describes two related experiences: a thinner, bonier-looking foot and new pain or discomfort in the heel or ball of the foot caused by reduced natural cushioning.
Despite the name, Ozempic itself does not appear to directly damage the feet. Instead, the likely explanation is the speed and amount of fat and muscle loss that can accompany effective weight-loss treatment. When the protective fat pads under the heel and forefoot become thinner, the foot has less shock absorption, which can make walking, standing, and exercise uncomfortable.
What People Mean by the Term
The phrase “Ozempic feet” emerged online as people using GLP-1 medications began reporting changes in their feet. It borrows the brand name Ozempic, but the same changes can occur after major weight loss from bariatric surgery, dieting, illness, or other causes.
There are two broad components:
| Type of change | What people notice | Likely explanation |
|---|---|---|
| Cosmetic | A narrower, bonier, “deflated,” or more skeletal-looking foot; visible veins and tendons; looser or wrinkled skin | Loss of subcutaneous fat under the skin and reduced skin elasticity after rapid weight loss. |
| Functional | Heel pain, soreness in the ball of the foot, burning, tenderness, calluses, blisters, or shoes that suddenly feel loose | Thinning of the plantar fat pads, possible loss of foot muscle, altered pressure distribution, and changes in shoe fit. |
The most important point is that “Ozempic feet” is not a single disease. It is a shorthand label for a collection of appearance changes and symptoms that may occur when the feet lose fat padding and soft-tissue support.
Why It Happens
The feet contain specialized fat pads beneath the heel and the ball of the foot. These pads act like built-in shock absorbers, spreading pressure across the sole and protecting bones, joints, tendons, and skin from repeated impact. When a person loses weight quickly, the volume of these pads can decrease along with fat elsewhere in the body.
As the cushioning thins, more pressure may be transferred directly to the heel bone and the metatarsal bones in the ball of the foot. This can produce a sensation often described as “walking on bone,” “walking on pebbles,” or having a bruised heel.
Rapid weight loss may also affect the skin. Skin has a degree of elasticity, but if fat disappears faster than the skin can contract, it may look loose, crepey, or saggy. This is especially noticeable on the top of the foot, where tendons and veins can become more prominent once the layer of fat between them and the skin becomes thinner.
Muscle loss may contribute as well. The small muscles within the foot help support the arch and stabilize movement. If weight loss includes substantial loss of muscle, the foot may become less stable, potentially changing gait and increasing stress on particular areas of the sole
Common Symptoms
Not everyone who loses weight on a GLP-1 medication will develop these changes. When they do occur, symptoms may include:
- A more prominent, bony appearance on the top of the foot.
- More visible veins and tendons.
- Loose, wrinkled, or sagging skin over the foot
- Heel pain or tenderness, especially when standing or walking.
- Pain or burning under the ball of the foot
- A feeling of reduced cushioning, sometimes described as walking on bone or pebbles.
- Shoes that feel too big, slip at the heel, or no longer fit properly.
- Increased calluses, blisters, or skin irritation from friction and pressure.
Foot size itself may not become shorter, but the volume and shape of the foot can change. A person may move from a wide shoe to a regular or narrow fit, or find that shoes that once felt secure now slide around.
Is It Dangerous?
For many people, “Ozempic feet” is primarily cosmetic or mildly uncomfortable. A thinner-looking foot does not automatically mean there is a serious medical problem. However, loss of padding can become functionally important if it causes persistent pain, alters the way a person walks, or leads to skin breakdown.
The concern is greater for people with diabetes, poor circulation, neuropathy, or a history of foot ulcers. In these groups, pressure points, blisters, calluses, and minor wounds can progress into serious ulcers or infections if they are not addressed promptly.
A person should seek medical or podiatric advice if foot pain is persistent or worsening, if they develop sores or ulcers, or if they notice redness, warmth, swelling, numbness, tingling, or difficulty walking.
How It Can Be Managed
There is no guaranteed way to prevent changes in the feet during weight loss, but several practical steps may reduce discomfort and protect foot health.
- Use supportive, cushioned footwear. Well-fitting shoes with adequate arch support and shock absorption can reduce pressure on the heel and forefoot.
- Replace worn-out shoes and reassess fit. After significant weight loss, a person may need a different shoe size, width, or style.
- Consider orthotics or cushioned insoles. A podiatrist may recommend inserts that restore some of the lost shock absorption and redistribute pressure.
- Maintain adequate protein intake. Protein supports muscle maintenance during weight loss, which may help preserve strength and stability in the feet and legs
- Include resistance training. Strength work for the legs, hips, calves, and feet may help maintain muscle support and improve balance.
- Stay hydrated and care for the skin. Moisturizing dry skin and avoiding cracks may reduce irritation, although hydration alone will not restore lost fat padding.
- Avoid walking barefoot on hard surfaces if it causes pain. Hard floors and pavement provide little cushioning when the natural fat pads have thinned.
- Discuss the pace of weight loss with a clinician. A slower, medically supervised approach may give skin and tissues more time to adapt, though slower loss does not eliminate the possibility of foot changes.
What the Evidence Shows
The biological mechanism is plausible: fat loss can reduce subcutaneous fat and plantar fat-pad volume, while loss of muscle can affect foot stability. Clinicians have long observed similar foot changes in patients who lose substantial weight for other reasons, including after bariatric surgery.
However, the specific term “Ozempic feet” is newer and largely anecdotal. It is not listed as a common side effect in the prescribing information for Ozempic, Wegovy, or other GLP-1 medications, and it is not an official diagnosis. The strongest evidence supports the general relationship between rapid weight loss and reduced foot padding or altered pressure distribution, rather than a unique direct effect of semaglutide on foot tissue.
The Bottom Line
“Ozempic feet” refers to thinner-looking, less-cushioned feet—and sometimes heel or forefoot pain—that some people experience after rapid weight loss on GLP-1 medications. It is best understood as a consequence of major fat and sometimes muscle loss, rather than as a direct injury caused by the drug itself.
For most people, supportive footwear, strength training, adequate nutrition, and attention to foot skin can help manage the issue. Anyone with diabetes, persistent pain, open sores, numbness, swelling, or difficulty walking should contact a healthcare professional or podiatrist promptly, because foot problems can become serious if left untreated.

